As modifications of PFN1 levels were previously shown to impact PTEN levels in breast tumour cells [34,38], we evaluated the protein levels of PTEN in PFN1 patient lymphoblasts by Western blot analysis. The gene discussed is PTEN; the disease is breast neoplasm.